Intravenous immunoglobulin or intralipid treatment for recurrent pregnancy loss or implantation failures women with NK cell abnormality
Not Applicable
Recruiting
- Conditions
- Recurrent pregnancy loss, implantation failure
- Registration Number
- JPRN-UMIN000038952
- Lead Sponsor
- Hyogo College of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Untreated other causes of infertility or RPL Allergy for IVIG or intralipid
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method For recurrent pregnancy loss women with NK cell abnormality: ongoing pregnancy rate at 22 weeks of pregnancy For implantation failure women with NK cell abnormality: pregnancy rate and ongoing pregnancy rate at 22 weeks of pregnancy
- Secondary Outcome Measures
Name Time Method